ChemicalBook >> CAS DataBase List >>Ramucirumab
Ramucirumab
- CAS No.
- 947687-13-0
- Chemical Name:
- Ramucirumab
- Synonyms
- Cyramza;LY3009806;IMC-1121B;Ramucirumab;Ramucirumab (anti-VEGFR2);Ramucirumab,NSCLC,non–small-cell lung cancer,gastric cancer,Inhibitor,VEGFR,Vascular endothelial growth factor receptor,inhibit,angiogenesis inhibitor
- CBNumber:
- CB72738188
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MFCD01092518
- MOL File:
- Mol file
Last updated:2023-05-21 10:59:17
| storage temp. | Store at -20°C |
|---|---|
| solubility | Soluble in DMSO |
| FDA UNII | D99YVK4L0X |
| NCI Dictionary of Cancer Terms | ramucirumab |
| NCI Drug Dictionary | ramucirumab |
| ATC code | L01XC21 |
Ramucirumab price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0031056 | Ramucirumab | 947687-13-0 | 1mg | $400 | 2021-12-16 | Buy |
| Biosynth Carbosynth | FR159043 | Ramucirumab | 947687-13-0 | 1mg | $425 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | ATB0023429 | RAMUCIRUMAB 95.00% | 947687-13-0 | 5MG | $498.75 | 2021-12-16 | Buy |
| Biosynth Carbosynth | FR159043 | Ramucirumab | 947687-13-0 | 2mg | $650 | 2021-12-16 | Buy |
| Biosynth Carbosynth | FR159043 | Ramucirumab | 947687-13-0 | 25mg | $2150 | 2021-12-16 | Buy |
Ramucirumab Chemical Properties,Uses,Production
Clinical Use
Human monoclonal antibody:
Treatment of advanced gastric cancer or gastrooesophageal junction adenocarcinoma, colorectal
cancer and non-small cell lung cancer (NSLC)
target
VEGFR2
Drug interactions
Potentially hazardous interactions with other drugs
Vaccines: risk of generalised infections with live
vaccines - avoid.
Metabolism
The metabolism of ramucirumab has not been studied. Monoclonal antibodies are mainly cleared by catabolism.
Ramucirumab Preparation Products And Raw materials
Raw materials
Preparation Products
Ramucirumab Suppliers
Global( 71)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Hubei Ipure Biology Co., Ltd | +8613367258412 | ada@ipurechemical.com | China | 10326 | 58 |
| HONG KONG IPURE BIOLOGY CO.,LIMITED | 86 18062405514 18062405514 | ada@ipurechemical.com | CHINA | 3465 | 58 |
| Shanghai Minbiotech Co., Ltd. | +8617315815539 | sales@minbiotech.com | CHINA | 129 | 58 |
| AFINE CHEMICALS LIMITED | 0571-85134551 18958018566; | info@afinechem.com | China | 15377 | 58 |
| Baoji Guokang Healthchem co.,ltd | +8615604608665 15604608665 | dominicguo@gk-bio.com | CHINA | 9427 | 58 |
| BOC Sciences | 16314854226; +16314854226 | inquiry@bocsci.com | United States | 19743 | 58 |
| Hefei Hirisun Pharmatech Co., Ltd | +8615056975894 | shawn@hirisunpharm.com | CHINA | 9923 | 58 |
| Wuhan Golt Biotech Co., Ltd. | +8615389281203 | maria@goltbiotech.com | China | 980 | 58 |
| Nantong HI-FUTURE Biology Co., Ltd. | +undefined18051384581 | sales@chemhifuture.com | China | 3136 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354 | support@targetmol.com | United States | 19973 | 58 |
947687-13-0(Ramucirumab)Related Search:
Ramucirumab
Ramucirumab,NSCLC,non–small-cell lung cancer,gastric cancer,Inhibitor,VEGFR,Vascular endothelial growth factor receptor,inhibit,angiogenesis inhibitor
Cyramza
IMC-1121B
LY3009806
Ramucirumab (anti-VEGFR2)
947687-13-0